NITROL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nitrol, and what generic alternatives are available?
Nitrol is a drug marketed by Rorer and Pohl Boskamp and is included in two NDAs. There is one patent protecting this drug.
The generic ingredient in NITROL is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nitrol
A generic version of NITROL was approved as nitroglycerin by AM REGENT on May 24th, 1988.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NITROL?
- What are the global sales for NITROL?
- What is Average Wholesale Price for NITROL?
Summary for NITROL
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 69 |
| Patent Applications: | 695 |
| Drug Prices: | Drug price information for NITROL |
| DailyMed Link: | NITROL at DailyMed |
US Patents and Regulatory Information for NITROL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rorer | NITROL | nitroglycerin | INJECTABLE;INJECTION | 018774-001 | Jan 19, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pohl Boskamp | NITROLINGUAL | nitroglycerin | AEROSOL;SUBLINGUAL | 018705-001 | Oct 31, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pohl Boskamp | NITROLINGUAL PUMPSPRAY | nitroglycerin | SPRAY, METERED;SUBLINGUAL | 018705-002 | Jan 10, 1997 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
More… ↓
